Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 26, 2025MedScienOpen Access

Comprehensive Advances in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Precision Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJiayi Sun

Discussion

Loading...

Member takes

Overview

Review synthesizes advances in non-small cell lung cancer, highlighting precision therapy and epigenetic dysregulation.

Key Points

  • Median survival for advanced patients exceeds 30 months due to new therapies and precision strategies.
  • Pathological complete response rates in early-stage patients improved tenfold with advanced targeted agents.
  • Assessment of treatment methods included integrating AI in liquid biopsy alongside historical treatment protocols.
  • Emerging therapies like antibody-drug conjugates are critical, pointing to a shift towards personalized medicine.

Cite This Study

Jiayi Sun (2025) studied this question.

synapsesocial.com/papers/68af7f397567bf4f94ff5e2ehttps://doi.org/10.61173/7f0ccx82
View Full Paper
Ask AI
Bookmark
Share